MediPharm Labs
In Canada and Australia, MediPharm Labs Corp. and its subsidiaries manufacture and sell pharmaceutical-grade cannabis oil and concentrates for derivative products. It also offers licensed producers and growers cannabis contract processing services, as well as tolling services to licensed cultivators in Canada.
Furthermore, the company provides purified cannabis concentrate raw materials as well as product formulations for ready-to-sell advanced cannabis products. Furthermore, it is involved in the real estate industry. The company was founded in 2015 and is based in Barrie, Ontario, Canada.
- OTCMKTS:MEDIF
- Stock Price: $0.45
- Consensus Rating: Buy (3 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
- Consensus Price Target: $1.56 (247.2% Upside)
Website: www.medipharmlabs.com
Market Cap: 44.938M